Research Papers

25 of 546 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Safety of inhaled nitric oxide withdrawal in severe chronic pulmonary hypertension.
Pérez-Peñate GM; Juliá-Serdá G; Galván-Fernández H; Alemán-Segura D; León-Marrero F; Garcia-Quintana A; de Larrinoa IR; Ortega-Trujillo JR; Gómez-Sánchez MÁ.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical tria…
Avitabile CM; Krishnan US; Yung D; Handler SS; Varghese N; Bates A; Fineman J; Sullivan R; Friere G; Austin E; Mullen MP; Pereira C; Christensen EJ; Yenokyan G; Collaco JM; Abman SH; Romer L; Dunbar Ivy D; Rosenzweig EB.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pulmonary artery wave intensity analysis in pulmonary hypertension associated with heart failure and reduced left ventr…
Yim IHW; Parker KH; Drury NE; Lim HS.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonar…
Kochanski JJ; Feinstein JA; Ogawa M; Ritter V; Hopper RK; Adamson GT.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retr…
Del Valle KT; Krowka MJ; Schinstock CA; Nath KA; Burger CD; Reddy YN; Frantz RP; Prakash YS; DuBrock HM.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical evaluation of code-based algorithms to identify patients with pulmonary arterial hypertension in healthcare da…
Didden EM; Lu D; Hsi A; Brand M; Hedlin H; Zamanian RT.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Structured evaluation of unclear dyspnea-An attempt to shorten the diagnostic delay in pulmonary arterial hypertension …
Ahmed S; Ahmed A; Rådegran G.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pulmonary hypertension patient perspectives toward pulmonary rehabilitation.
Bailey M; DuBrock HM.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Patients with CTEPH and mild hemodynamic severity of disease improve to a similar level of exercise capacity after pulm…
van Kan C; Tramper J; Bresser P; J Meijboom L; Symersky P; Winkelman JA; Nossent EJ; Aman J; Bogaard HJ; Vonk Noordegraaf A; van Es J.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus s…
Shlobin OA; Shen E; Wort SJ; Piccari L; Scandurra JA; Hassoun PM; Nikkho SM; Nathan SD.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
CS1, a controlled-release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertens…
Benza RL; Adamson PB; Bhatt DL; Frick F; Olsson G; Bergh N; Dahlöf B.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis.
Nathan SD; Tehrani B; Zhao Q; Arias R; Kim D; Pellegrini A; Collins AC; Diviney J; Chakravorty S; Khangoora V; Shlobin OA; Thomas C; Lavon BR; King CS; Chandel A.
Pulm Circ (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Safety and efficacy of balloon pulmonary angioplasty for technically operable chronic thromboembolic pulmonary hyperten…
Wang J; Liu J; Tao X; Xie W; Wang S; Zhang S; Zhang Z; Fu Z; Li H; Zhang Y; Li Y; Li X; Zhang Y; Xi L; Liu D; Huang Q; Zhao Y; Zhai Z.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Remote exercise testing in pulmonary hypertension (PHRET).
Stubbs H; Lua S; Ingram J; Jani BD; Brewis M; Church C; Johnson M.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus …
Morland K; Gerges C; Elwing J; Visovatti SH; Weatherald J; Gillmeyer KR; Sahay S; Mathai SC; Boucly A; Williams PG; Harikrishnan S; Minty EP; Hobohm L; Jose A; Badagliacca R; Lau EMT; Jing ZC; Vanderpool RR; Fauvel C; Leonidas Alves J; Strange G; Pulido T; Qian J; Li M; Mercurio V; Zelt JGE; Moles VM; Cirulis MM; Nikkho SM; Benza RL; Elliott CG.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identification of monocyte-associated pathways participated in the pathogenesis of pulmonary arterial hypertension base…
Zhong C; Si Y; Yang H; Zhou C; Chen Y; Wang C; Liu Y; Chen C; Shi H; Lai X; Tang H.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Quantitative CT measures of pulmonary vascular volume distribution in pulmonary hypertension associated with COPD: Asso…
Cajigas HR; Lavon B; Harmsen W; Muchmore P; Costa J; Mussche C; Pulsipher S; De Backer J.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Pulmonary artery dilatation in different causes of pulmonary hypertension.
Xi Q; Liu Z; Xiong C; Luo Q; Zhao Z; Zhao Q; Yang T; Zeng Q; Li P; Qiu L.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Left ventricular underfilling in PAH: A potential indicator for adaptive-to-maladaptive transition.
Guo J; Wang J; Wang L; Li Y; Xu Y; Li W; Chen C; He J; Yin L; Pu S; Wen B; Han Y; Chen Y.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
4D-Flow MRI intracardiac flow analysis considering different subtypes of pulmonary hypertension.
Cain MT; Schäfer M; Ross LK; Ivy DD; Mitchell MB; Fenster BE; Bull TM; Barker AJ; Vargas D; Hoffman JRH.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Differential drug response in pulmonary arterial hypertension: The potential for precision medicine.
Miller E; Sampson CU; Desai AA; Karnes JH.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary…
Collaco JM; Abman SH; Austin ED; Avitabile CM; Bates A; Fineman JR; Freire GA; Handler SS; Ivy DD; Krishnan US; Mullen MP; Varghese NP; Yung D; Nies MK; Everett AD; Zimmerman KO; Simmons W; Chakraborty H; Yenokyan G; Newell-Sturdivant A; Christensen E; Eyzaguirre LM; Hanley DF; Rosenzweig EB; Romer LH.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessing the optimal MAP target in pre-capillary PH patients with RV failure: A retrospective analysis.
Moallem N; Fiscus G; O'Sullivan DM; Perkins M; Scatola A; Parikh R.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Lianhua Qingke ameliorates lipopolysaccharide-induced lung injury by inhibiting neutrophil extracellular traps formatio…
Peng W; Qi H; Zhu W; Tong L; Rouzi A; Wu Y; Han L; He L; Yan Y; Pan T; Liu J; Wang Q; Jia Z; Song Y; Zhu Q; Zhou J.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in <i>bmpr2</i>-silenced huma…
Tielemans B; Wagenaar A; Belge C; Delcroix M; Quarck R.
Pulm Circ (Unknown)
Published: 2023
3/6 Transparent
Funding Declared